Polynovo

Polynovo EBIT

The EBIT of Polynovo (PNV.AX) as of Oct 28, 2026 is 11.25 M AUD. In the previous year, EBIT was 7.76 M AUD — a change of 45.09% (higher).

EBIT

11.25 MAUD

YoY

45.09%

Last updated:

In 2026, Polynovo's EBIT was 11.25 M AUD, a 45.09% increase from the 7.76 M AUD EBIT recorded in the previous year.

The Polynovo EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2024
1.16 M AUD
Jan 1, 2025
7.76 M AUD
Jan 1, 2026
11.25 M AUD
Jan 1, 2027 (e)
10.81 M AUD
Jan 1, 2028 (e)
19.70 M AUD
Jan 1, 2029 (e)
30.48 M AUD
Jan 1, 2030 (e)
65.43 M AUD
Jan 1, 2031 (e)
0.00 AUD
The Polynovo EBIT history
YEAREBITYoY
est0.00AUD-100.00%
est65.43 MAUD+114.65%
est30.48 MAUD+54.74%
est19.70 MAUD+82.28%
est10.81 MAUD-3.95%
11.25 MAUD+45.09%
7.76 MAUD+566.81%
1.16 MAUD-118.80%
-6.19 MAUD+2,306.61%
-257,000.00AUD-96.31%
-6.96 MAUD+68.04%
-4.14 MAUD-32.81%
-6.16 MAUD-13.08%
-7.09 MAUD+37.78%
-5.15 MAUD+17.65%
-4.37 MAUD+10.18%
-3.97 MAUD-3.55%
-4.12 MAUD+20.25%
-3.42 MAUD-15.94%
-4.07 MAUD+5.11%
-3.87 MAUD+19.91%
-3.23 MAUD+8.61%
-2.97 MAUD-44.93%
-5.40 MAUD-63.61%
-14.84 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Polynovo Revenue

Polynovo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
103.19 M AUD
1.16 M AUD
5.26 M AUD
Jan 1, 2025
127.24 M AUD
7.76 M AUD
13.21 M AUD
Jan 1, 2026
143.71 M AUD
11.25 M AUD
7.34 M AUD
Jan 1, 2027 (e)
161.78 M AUD
10.81 M AUD
8.36 M AUD
Jan 1, 2028 (e)
185.70 M AUD
19.70 M AUD
15.19 M AUD
Jan 1, 2029 (e)
212.58 M AUD
30.48 M AUD
24.57 M AUD
Jan 1, 2030 (e)
235.13 M AUD
65.43 M AUD
46.52 M AUD
Jan 1, 2031 (e)
250.89 M AUD
0.00 AUD
57.99 M AUD

Polynovo Margins

Polynovo stock margins

The Polynovo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Polynovo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Polynovo.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
94.69 %
1.13 %
5.10 %
Jan 1, 2025
95.92 %
6.09 %
10.38 %
Jan 1, 2026
32.70 %
7.83 %
5.11 %
Jan 1, 2027 (e)
32.70 %
6.68 %
5.16 %
Jan 1, 2028 (e)
32.70 %
10.61 %
8.18 %
Jan 1, 2029 (e)
32.70 %
14.34 %
11.56 %
Jan 1, 2030 (e)
32.70 %
27.83 %
19.78 %
Jan 1, 2031 (e)
32.70 %
0.00 %
23.11 %

Polynovo Stock analysis

What does Polynovo do? Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Polynovo's EBIT

Polynovo's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Polynovo's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Polynovo's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Polynovo’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Polynovo stock

EBIT of Polynovo is 11.25 M AUD in 2026.

EBIT of Polynovo changed from 7.76 M AUD to 11.25 M AUD, representing a 45.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Polynovo since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Polynovo historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Polynovo

All Key Metrics — Polynovo